Healios K.K.
TSE:4593.T
Overview | Financials
Company Name | Healios K.K. |
Symbol | 4593.T |
Currency | JPY |
Price | 224 |
Market Cap | 20,189,120,448 |
Dividend Yield | 0% |
52-week-range | 114 - 255 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Tadahisa S. Kagimoto M.D. |
Website | https://www.healios.co.jp |
An error occurred while fetching data.
About Healios K.K.
Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company is also developing cellular and tissue-based products comprising HLCR011 and HLCR012 that are iPSC regenerative medicines for the treatment of age-related macular degeneration;
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD